Mouse models of acute and chronic hepacivirus infection.
Eva BillerbeckRaphael WolfisbergUlrik FahnøeJing W XiaoCorrine QuirkJoseph M LunaJohn M CullenAlex S HartlageLuis A ChiribogaKalpana GhoshalW Ian LipkinJens BukhTroels Kasper Høyer ScheelAmit KapoorCharles M RicePublished in: Science (New York, N.Y.) (2018)
An estimated 71 million people worldwide are infected with hepatitis C virus (HCV). The lack of small-animal models has impeded studies of antiviral immune mechanisms. Here we show that an HCV-related hepacivirus discovered in Norway rats can establish high-titer hepatotropic infections in laboratory mice with immunological features resembling those seen in human viral hepatitis. Whereas immune-compromised mice developed persistent infection, immune-competent mice cleared the virus within 3 to 5 weeks. Acute clearance was T cell dependent and associated with liver injury. Transient depletion of CD4+ T cells before infection resulted in chronic infection, characterized by high levels of intrahepatic regulatory T cells and expression of inhibitory molecules on intrahepatic CD8+ T cells. Natural killer cells controlled early infection but were not essential for viral clearance. This model may provide mechanistic insights into hepatic antiviral immunity, a prerequisite for the development of HCV vaccines.
Keyphrases
- hepatitis c virus
- drug induced
- liver injury
- regulatory t cells
- human immunodeficiency virus
- sars cov
- high fat diet induced
- endothelial cells
- natural killer cells
- poor prognosis
- mouse model
- dendritic cells
- respiratory failure
- adipose tissue
- metabolic syndrome
- immune response
- insulin resistance
- brain injury
- preterm birth